We are live on
!
Find out more
PCM
Pyrrho Capital Management Portfolio holdings
AUM
$66.5M
1-Year Est. Return
7.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.85%
1 Year Est. Return
-7.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$148M
AUM Growth
+$32.4M
(+28%)
Cap. Flow
-$40.9M
Cap. Flow
% of AUM
-27.64%
Top 10 Holdings %
Top 10 Hldgs %
98.06%
Holding
47
New
7
Increased
3
Reduced
4
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$9.77M |
| 2 |
AGN
Allergan plc
AGN
|
+$3.48M |
| 3 |
DHT Holdings
DHT
|
+$1.59M |
| 4 |
ALDR
Alder Biopharmaceuticals
ALDR
|
+$1.43M |
| 5 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$867K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$7.04M |
| 2 |
DigitalBridge
DBRG
|
+$5.88M |
| 3 |
XPO
XPO
|
+$3.9M |
| 4 |
DRII
DIAMOND RESORTS INTL, INC
DRII
|
+$3.23M |
| 5 |
Ardmore Shipping
ASC
|
+$2.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 85.65% |
| 2 | Healthcare | 6.36% |
| 3 | Consumer Discretionary | 3.55% |
| 4 | Energy | 2.57% |
| 5 | Industrials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.03B
| $69.5M | 46.93% |
+990,000
| New | +$53.6M |
|
2
CALL
iShares S&P 100 ETF
OEF
$20.5B
| $47.2M | 31.87% |
+139,500
| New | +$12.8M |
|
|
3
iShares Biotechnology ETF
IBB
$10.8B
| $10.2M | 6.85% |
+90,000
| New | +$9.77M |
|
|
DRII
4
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $4.55M | 3.07% |
178,423
-122,970
| -41% | -$3.23M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $3.66M | 2.47% |
+11,700
| New | +$3.48M |
|
|
ZGNX
6
DELISTED
Zogenix, Inc.
ZGNX
| $2.19M | 1.48% |
148,260
+17,860
| +14% | +$240K |
|
7
Scorpio Tankers
STNG
$3.88B
| $2.17M | 1.46% |
27,000
+3,912
| +17% | +$348K |
|
|
8
Ardmore Shipping
ASC
$721M
| $2.1M | 1.42% |
165,140
-231,100
| -58% | -$2.91M |
|
|
ALDR
9
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.08M | 1.41% |
63,000
+42,343
| +205% | +$1.43M |
|
|
10
DHT Holdings
DHT
$3.12B
| $1.64M | 1.11% |
+202,500
| New | +$1.59M |
|
|
RVNC
11
DELISTED
Revance Therapeutics, Inc.
RVNC
| $854K | 0.58% |
+25,000
| New | +$867K |
|
12
Service Corp International
SCI
$11.4B
| $703K | 0.47% |
27,000
-33,000
| -55% | -$902K |
|
13
Green Plains
GPRE
$984M
| $676K | 0.46% |
+29,518
| New | +$626K |
|
|
BDSI
14
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $647K | 0.44% |
135,000
-142,422
| -51% | -$807K |
|
15
AerCap
AER
$23.3B
| – | – |
-55,000
| Closed | -$2.1M |
|
16
Ally Financial
ALLY
$13B
| – | – |
-97,048
| Closed | -$1.98M |
|
17
Aptiv
APTV
$9.43B
| – | – |
-15,000
| Closed | -$1.14M |
|
18
CALL
Bausch Health
BHC
$2.36B
| – | – |
-5,000
| Closed | -$892K |
|
|
19
Bausch Health
BHC
$2.36B
| – | – |
-10,000
| Closed | -$1.78M |
|
20
CALL
Blackstone
BX
$108B
| – | – |
-76,425
| Closed | -$2.38M |
|
21
Coherus Oncology
CHRS
$226M
| – | – |
-27,133
| Closed | -$544K |
|
22
Cemex
CX
$15.8B
| – | – |
-162,240
| Closed | -$1.05M |
|
|
23
DigitalBridge
DBRG
$2.99B
| – | – |
-102,274
| Closed | -$5.88M |
|
24
DuPont de Nemours
DD
$18.7B
| – | – |
-9,872
| Closed | -$1.06M |
|
25
Delek US
DK
$4.3B
| – | – |
-18,800
| Closed | -$521K |
|
Similar funds
GCP
NCIM
NA
SAM
TF
OL
JPC
FNYS
Pyrrho Capital Management's Q4 2015 Portfolio in Review
As of Q4 2015, Pyrrho Capital Management held 47 positions worth $148M, up 28% from $116M the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Pyrrho Capital Management withdrew a net $40.9M in Q4 2015, closing 33 positions and reducing 4 holdings. Its most notable exit was NorthStar Realty Finance Corp., an estimated $7.04M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Pyrrho Capital Management opened a new position in iShares Biotechnology ETF worth $10.2M.
- Pyrrho Capital Management's largest Q4 2015 buy was iShares Biotechnology ETF: 90,000 shares worth $10.2M.
- Pyrrho Capital Management added most to Alder Biopharmaceuticals in Q4 2015, an estimated $1.43M increase.
- Pyrrho Capital Management's biggest Q4 2015 reduction was DIAMOND RESORTS INTL, INC, cutting an estimated $3.23M.
- Pyrrho Capital Management fully exited NorthStar Realty Finance Corp. in Q4 2015, selling an estimated $7.04M.
- Pyrrho Capital Management's ten largest holdings make up 98% of its $148M portfolio in Q4 2015.
- Pyrrho Capital Management opened 7 new positions and closed 33 in Q4 2015.
- Pyrrho Capital Management's portfolio value rose 28% quarter-over-quarter to $148M.
Based on Pyrrho Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.